Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Gait variability as a marker of white matter integrity in individuals with Down syndrome

Producción científica: Articlerevisión exhaustiva

2 Citas (Scopus)

Resumen

INTRODUCTION: Individuals with Down syndrome (DS) face a significant risk of neurodegeneration, and gait variability may serve as a clinical biomarker of neurological health. This longitudinal parent substudy aimed to explore relationships between gait, white matter (WM) integrity, and cognitive function in DS. METHODS: The associations were investigated between magnetic resonance imaging diffusion tensor imaging (DTI), cognition, and self-paced gait data from 22 DS participants (mean age ± SD 37 ± 7.5 years). RESULTS: DTI measures, such as lower fractional anisotropy (FA) and higher mean diffusivity, were correlated with greater step time variability but not normalized velocities. Lower cognitive scores on the Vineland Adaptive Behavior Composite, Dementia Questionnaire for People with Learning Disabilities, and Motor Skill subscale were correlated with FA. DISCUSSION: Gait variability correlates with WM integrity and cognitive function in DS, suggesting that gait and DTI measures may serve as clinical markers of neurological decline. Highlights: Gait variability linked to white matter integrity in individuals with Down syndrome (DS). Lower fractional anisotropy and higher mean diffusivity are associated with increased step time variability in DS. Cognitive decline is tied to white matter changes in motor-related brain regions. Gait analysis alongside diffusion tensor imaging may aid in screening for cognitive impairment in DS.

Idioma originalEnglish
Número de artículoe70407
PublicaciónAlzheimer's and Dementia
Volumen21
N.º7
DOI
EstadoPublished - jul 2025

Nota bibliográfica

Publisher Copyright:
© 2025 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Financiación

The authors are grateful to the study participants, their families, and all the research and support staff. This manuscript has been reviewed by all authors. The content is solely the responsibility of the authors. This work was supported by National Institutes of Health (NIH) grant R01‐HD064993, Aging and Dementia in Down Syndrome: Connectivity, Inflammation, and Cerebrovascular Contributions. The work was also supported by the Alzheimer's Biomarkers Consortium–Down Syndrome (ABC‐DS) and was funded by the National Institute on Aging and the National Institute for Child Health and Human Development (U19 AG068054).

FinanciadoresNúmero del financiador
National Institute on Aging
Alzheimer's Biomarkers Consortium
National Institutes of Health (NIH)R01‐HD064993
NIH National Institute of Child Health and Human Development National Center for Medical Rehabilitation ResearchU19 AG068054

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Epidemiology
    • Health Policy
    • Developmental Neuroscience
    • Clinical Neurology
    • Geriatrics and Gerontology
    • Cellular and Molecular Neuroscience
    • Psychiatry and Mental health

    Huella

    Profundice en los temas de investigación de 'Gait variability as a marker of white matter integrity in individuals with Down syndrome'. En conjunto forman una huella única.

    Citar esto